TRY NOW

Enhance and accelerate your early stage research with trusted and comprehensive intelligence from Thomson Reuters.

Start your free trial in just two simple steps.

Get your FREE trial

Enrich your discovery science with market leading, manually curated scientific intelligence. Systems Biology, Preclinical, Biomarkers, Chemistry, Biology, and Pharmacology - and everything in between. Covered from the perspective that matters most – yours.
Customer Feedback
Customer Feedback

Annette Bakker, Chief Scientific Officer from CTF, explains the reasons why she likes to work with Thomson Reuters. Currently using MetaCore™ to identify disease treatment options.

Live & Recorded Training

Attend one of our regularly scheduled webinar training sessions for overviews of features, tools, and content – find the schedule here

Free Pathway Maps

Search or browse through a wide range of proprietary multi-step canonical pathway maps here.

Featured News

The latest news from Life Sciences Research
The future of COPD treatment

The future of COPD treatment

Our research shows greater focus on preventative therapies

Translational Medicine

Translational Medicine

Supplement-Size Doses of Antioxidants Hasten Lung Cancer Progression

Tet Proteins Erase Epigenetic Marks

Tet Proteins Erase Epigenetic Marks

It is (reasonably) common knowledge that DNA is written in a simple four-letter code: ACTG. Too simple, actually.

Blog Highlights

Read our latest blog posts

New Sunscreen Approval—Why So Complicated?

Topically-applied sunscreen product use is a billion-dollar industry. The use of these products over the last 40 years has changed dramatically from a “niche” market ...

Reflecting on Generic Market Trends

Some key industry events are just around the corner, and many of the themes that ran throughout last year will likely continue to resonate in ...

Notable Deals in the Pharmaceutical Industry in the 4th Quarter of 2014

During the 4th quarter of 2014, Cortellis Competitive Intelligence had 583 new deals added as part of its ongoing coverage of pharmaceutical licensing activity compared ...

Whitepapers & Publications

View our recent whitepapers and publications

BioMarker White Paper

Biomarkers: An indispensible addition to the drug development toolkit

THE YEAR'S NEW DRUGS & BIOLOGICS, 2013: PART I

http://dx.doi.org/10.1358/dot.2014.50.1.2116673

Latest on Twitter

Latest on Linked In